By focusing on innovative, long-lasting pain relief methods, Brixton is well-positioned to contribute to the shift away from opioid dependence. The company’s technologies align with the objectives of ...

Lorecivivint was effective for managing symptoms of moderate to severe knee OA while providing structural benefits.

Authors of a new 407-patient study, sponsored by Novo Nordisk, wrote that obese patients with knee osteoarthritis (OA) and ...

Once-weekly semaglutide shows significant reduction in knee osteoarthritis pain and body weight in adults with obesity, a ...

A new study shows that Ozempic may help ease arthritis knee pain in people with obesity. Here's what to know about the study ...

Knee injuries are common in athletes, accounting for 41% of all athletic injuries. But knee injuries aren't limited to ...

Both studies were presented at the American College of Rheumatology (ACR) annual meeting.

Long acting injection Fluticasone promising in knee osteoarthritis suggests a new study published in the The Lancet ...

Medicare does not cover platelet rich plasma injections for any health condition. Learn what you can expect to pay for them.

A new study published in the New England Journal of Medicine showed that once-weekly injectable semaglutide led to ...

Enlivex (ENLV) has released an update. Enlivex Therapeutics has commenced the next phase of its Allocetra trial, enrolling and dosing the first ...